Health care startups that raised Series A in Belgium
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Amyl Therapeutics | Liège | Series A | $9.6M | 2026-09-01 |
| Bioxodes | Marche-en-famenne | Series A | $6.4M | 2025-12-10 |
| Axiles Bionics | Brussel | Series A | $7.0M | 2025-06-24 |
| Augustine Therapeutics | Leuven | Series A | $83.9M | 2025-03-24 |
| Minze Health | Antwerp | Series A | $5.3M | 2024-10-17 |
| PanTera | Mol | Series A | $110.3M | 2024-09-11 |
| LynxCare | Leuven | Series A | $21.1M | 2022-06-21 |
| Oncomfort | Brussels | Series A | $11.8M | 2020-09-09 |
8 rows of the CSV in 5 of its 18 columns.
- The 35 health care startups in Belgium whose last round is Series A have raised $546.5M in total.
- 4 of them closed their most recent round in the last 12 months, $148.9M combined.
- The largest of those rounds is Coultreon Biopharma's $125.0M Series A, dated April 2026.
- The most recent is 4Tissue's $7.9M Series A on 20 October 2026.
- PMV is an investor in 5 of them, more than any other fund.
- Biotech is the most common other sector, with 22 companies (63%).
- 26% were founded in 2020 or later; the median founding year is 2017.
- The most common team size is 11 to 50 employees (74% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
10 of 35| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Amyl Therapeutics | Amyl Therapeutics is a preclinical biotechnology company developing immunotherapy for neurodegenerative diseases. | Biotech | Liège | Series A | $9.6M | 2026-09-01 | $44.0M | Meusinvest (Noshaq), Sambrinvest, Mérieux Equity Partners +1 | 1 to 10 | 2020 |
| Bioxodes | Bioxodes develops high value products derived from natural sources. | Biotech | Marche-en-famenne | Series A | $6.4M | 2025-12-10 | $25.6M | European Commission | 11 to 50 | 2013 |
| Axiles Bionics | Axiles Bionics makes new generation bionic feet that improve quality of life for amputees. | Hardware | Brussel | Series A | $7.0M | 2025-06-24 | $9.4M | European Innovation Council | 11 to 50 | 2019 |
| Augustine Therapeutics | Augustine Therapeutics discovers and develops medicines for neuromuscular and neurodegenerative diseases. | Biotech | Leuven | Series A | $83.9M | 2025-03-24 | $106.8M | PMV, V-Bio Ventures, VIB | 11 to 50 | 2019 |
| Minze Health | Minze Health builds digital health solutions for urology and pelvic health. | Health care | Antwerp | Series A | $5.3M | 2024-10-17 | $9.4M | PMV, Capricorn Partners, imec.istart Future Fund +1 | 11 to 50 | 2015 |
| PanTera | PanTera produces actinium-225 for personalized cancer treatment and radiopharmaceuticals. | Health care | Mol | Series A | $110.3M | 2024-09-11 | Eurazeo, PMV, EQT Life Sciences +2 | 11 to 50 | 2022 | |
| LynxCare | LynxCare provides a big data platform for hospitals and clinics. | Artificial intelligence | Leuven | Series A | $21.1M | 2022-06-21 | Alchemist Accelerator, Elaia, PMV +2 | 11 to 50 | 2015 | |
| Oncomfort | Oncomfort offers virtual reality therapy sessions that relieve patients' pain and anxiety as digital sedation. | Hardware | Brussels | Series A | $11.8M | 2020-09-09 | $14.7M | Crédit Mutuel Innovation, Debiopharm Innovation Fund, Be Angels +2 | 11 to 50 | 2015 |
| Twikit | Twikit provides software for scalable product individualization connected to digital manufacturing processes. | Commerce | Antwerp | Series A | $2.7M | 2020-02-14 | $7.9M | Asimov Ventures, Buysse & Partners, HP Tech Ventures | 11 to 50 | 2012 |
| ONTOFORCE | ONTOFORCE is a Belgian semantic technology company that provides solutions for improving information management. | Biotech | Ghent | Series A | $5.3M | 2018-01-25 | PMV, Limburgse Reconversie Maatschappij, Korys | 11 to 50 | 2011 |
Table 1. Health care startups that raised Series A in Belgium: the 10 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 35.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Amyl Therapeutics | Amyl Therapeutics is a preclinical biotechnology company developing immunotherapy for neurodegenerative diseases. | Biotech | Liège | Series A | $9.6M | 2026-09-01 | $44.0M | Meusinvest (Noshaq), Sambrinvest, Mérieux Equity Partners +1 | 1 to 10 | 2020 |
| 2 | Bioxodes | Bioxodes develops high value products derived from natural sources. | Biotech | Marche-en-famenne | Series A | $6.4M | 2025-12-10 | $25.6M | European Commission | 11 to 50 | 2013 |
Table 2. Health care startups that raised Series A in Belgium: the 2 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | PMV | Government investment office | Brussels, Belgium | 5 | 14% | ||
| 2 | Meusinvest (Noshaq) | Venture capital firm | Liège, Belgium | 1 | 3% | 1 | Amyl Therapeutics |
| 3 | Mérieux Equity Partners | Private equity firm | Lyon, France | 1 | 3% | 1 | Amyl Therapeutics |
| 4 | Smedvig | Family office | Stavanger, Norway | 1 | 3% | 1 | Amyl Therapeutics |
| 5 | Sambrinvest | Venture capital firm | Gosselies, Belgium | 1 | 3% | 1 | Amyl Therapeutics |
| 6 | European Commission | Government investment office | Brussels, Belgium | 1 | 3% | 1 | Bioxodes |
| 7 | European Innovation Council | Startup accelerator | Brussels, Belgium | 1 | 3% | ||
| 8 | VIB | Venture capital firm | Ghent, Belgium | 1 | 3% | ||
| 9 | V-Bio Ventures | Venture capital firm | Ghent, Belgium | 1 | 3% | ||
| 10 | imec.istart Future Fund | Venture capital firm | Antwerp, Belgium | 1 | 3% | ||
| 11 | White Fund | Private equity firm | Liège, Belgium | 1 | 3% | ||
| 12 | Capricorn Partners | Venture capital firm | Leuven, Belgium | 1 | 3% | ||
| 13 | Eurazeo | Private equity firm | Paris, France | 1 | 3% | ||
| 14 | KBC | Investment bank | Brussels, Belgium | 1 | 3% | ||
| 15 | Kurma Partners | Venture capital firm | Paris, France | 1 | 3% |
Table 3. Health care startups that raised Series A in Belgium: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Biotech | 22 | 63% | $497.7M |
| Software | 9 | 26% | $44.0M |
| Hardware | 3 | 9% | $24.2M |
| Artificial intelligence | 1 | 3% | |
| Commerce | 1 | 3% | $7.9M |
Table 4. Health care startups that raised Series A in Belgium by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series A | 35 | 100% | $7.9M |
Table 5. Health care startups that raised Series A in Belgium by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| Liège | 4 | 11% |
| Ghent | 3 | 9% |
| Leuven | 3 | 9% |
| Louvain-la-neuve | 3 | 9% |
| Brussels | 2 | 6% |
| Antwerp | 2 | 6% |
| Hasselt | 2 | 6% |
| Diepenbeek | 2 | 6% |
| Heverlee | 1 | 3% |
| Marche-en-famenne | 1 | 3% |
| Brussel | 1 | 3% |
| Aye | 1 | 3% |
Table 6. Health care startups that raised Series A in Belgium by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 1 | 25% | $7.9M |
| September 2026 | 1 | 25% | $9.6M |
| April 2026 | 1 | 25% | $125.0M |
| December 2025 | 1 | 25% | $6.4M |
Table 7. Health care startups that raised Series A in Belgium: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 3 | 9% | $142.4M |
| 2025 | 4 | 11% | $99.9M |
| 2024 | 4 | 11% | $188.8M |
| 2023 | 3 | 9% | $58.2M |
| 2022 | 1 | 3% | $21.1M |
| 2021 | 3 | 9% | $56.7M |
Table 8. Health care startups that raised Series A in Belgium by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 3 | 9% |
| 2020 to 2022 | 6 | 17% |
| 2015 to 2019 | 15 | 43% |
| 2010 to 2014 | 8 | 23% |
| Before 2010 | 3 | 9% |
Table 9. Health care startups that raised Series A in Belgium by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 8 | 23% |
| 11 to 50 | 26 | 74% |
| 51 to 100 | 1 | 3% |
Table 10. Health care startups that raised Series A in Belgium by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its most recent funding round is Series A and its headquarters is in Belgium. On 16 November 2026 that is 35 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 10 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 35 rows: 3 have no round amount, 0 no city and 10 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in Belgium whose last round is Series A are on the list?
- 35, in the file dated 16 November 2026. 4 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 35 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.